头像

仇文卫

  • 个人资料
    • 部门: 化学与分子工程学院
    • 性别:
    • 专业技术职务: 教授 博士生导师
    • 毕业院校:
    • 学位:
    • 学历: 博士
    • 联系电话: 021-54340103
    • 电子邮箱: wwqiu@chem.ecnu.edu.cn
    • 办公地址: 华东师大化学系(闵行)525室
    • 通讯地址: 华东师大化学系(闵行)525室
    • 邮编:
    • 传真: 021-54340103

    工作经历

    2019.12-今:华东师范大学 化学与分子工程学院 教授

    2009.12-2019.12:华东师范大学 化学与分子工程学院 副教授

    2010.10-2011.10:哈佛大学访问学者(Professor E. J. Corey)

    2006.09-2009.12:华东师范大学 化学与分子工程学院 讲师


    教育经历

    2003.09-2006.07:中科院上海药物研究所 理学博士

    2000.09-2003.07:华东师范大学 理学硕士

    1993.09-1997.07:常州大学 工学学士


    个人简介

    社会兼职

    研究方向

    研究方向: 1、甾体新药研究  2、甾体药物绿色制造工艺研究

    招生方向: 1、药学(药物化学,硕士、博士) 2、生物与医药工程(制药工程,硕士、博士)

    招生与培养

    开授课程

    研究生:《制药工程》

    本科生:《有机化学实验》、《药物合成-从实验室到工业化》

    科研项目

    主持科研项目:

    一、基础研究项目:

    1、 国家自然科学基金面上项目:HMGCR泛素化降解剂的设计、合成及其降胆固醇活性研究。(项目号:22077035),执行年限2021.1-2024.12

    2、国家自然科学基金重大研究计划子课题:蛋白质胆固醇动态修饰的调控机制、化学干预和功能研究。(项目编号:14303-41211-18025),执行年限2018.1-2021.12

    3、上海市自然科学基金:抗结肠癌先导化合物的发现、结构优化及其抗肿瘤活性研究。(项目号:18ZR1411200),执行年限:2018.7-2021.6

    4、 国家自然科学青年基金:新型PTP1B抑制剂-山楂酸衍生物的分子设计‚合成与活性研究。(项目号:20802020)执行年限:2009.1-2011.12

    5、教育部博士点新教师基金:新型蛋白酪氨酸酯酶IB抑制剂-山楂酸衍生物的构效关系研究。(项目号:200802691039)执行年限:2009.1-2011.12

    6、上海市自然科学基金:甾类衍生物的设计合成及其促羟甲基戊二酰辅酶A还原酶的泛素化降解活性研究。(项目号:12ZR1408500)执行年限:2012.7-2015.6

    7、 华东师范大学创新基金面上项目:水溶性白桦脂酸衍生物的设计、合成及其对破骨细胞生成抑制的活性研究(项目号:78260001)执行年限:2013.1-2014.12

    二、应用研究项目:

    8、胆甾类药物及其衍生物的绿色制造及其创新工艺研究,1000万,主持,2023.11-2028.10

    9、基于9-羟基-ADBA的甾体药物绿色制造工艺研究,600万,主持,2019.11-2023.10

    10、甾体药物绿色制造工艺研究,200万,主持,2017.11-2022.12

    11、9α-羟基雄甾-4--3,17-二酮的衍生化产品工艺研究,160万,主持,2014.7-2021.12

    12、甾体药物合成新工艺研究,100万,主持,2016.1-2017.12

    13、发明专利转让一种以BA为原料合成熊去氧胆酸的方法,250万,主持,2020.1


    学术成果

    发表文章及专利:


    49.  Shuan-Jing Wang, Jiahui Zhang, Jin-Zan Zhang, Ruo-Nan Ning, Chen-Chen Li, Xing Xu*, Min Jiang*, Wen-Wei Qiu*Synthesis and Biological Evaluation of Heterocyclic Ring-Fused 20(S)‑Protopanaxadiol Derivatives as Potent Antiosteoporosis Agents. J. Med. Chem2023, 66, 11965-11984.


    48. Xing-Zi Li, Shi-You Jiang, Guo-Qiang Li, Qian-Ru Jiang, Jue-Wan Li, Chen-Chen Li, Yu-Qin Han, Bao-Liang Song, Xin-Ran Ma*, Wei-Qi*Wen-Wei Qiu*Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterolEur. J. Med. Chem2022236, 114323.


    47. Ao Hu, Jing-Zan Zhang, Jie Wang, Chen-Chen Li, Meng Yuan, Gang Deng, Zi-Cun Lin, Zhi-Ping Qiu, Hu-Yue Liu, Xian-Wei Wang, Peng-Cheng Wei, Xiao He, Xiaolu Zhao*, Wen-Wei Qiu* and Bao-Liang Song*. Cholesterylation of Smoothened is a calcium-accelerated autoreaction involving an intramolecular ester intermediate. Cell Research 2022, 32, 288-301.


    46. Xing-Zi Li, Chen-Chen Li, Cheng-Yu Jiang, Zhi-Liang Jing, Xiang-Zhong Gu, Hao-Jie Ni, Wen-Wei Qiu*. Synthesis of plant-derived cholesterol from bisnoralcohol. Steroids  2022178, 108967.


    45. Dandan Guo, Liming He, Yaoxin Gao, Chenxu Jin, Haizhen Lin, Li Zhang, Liting Wang, Ying Zhou, Jie Yao, Yixin Duan, Renzheng Yang, Wenwei Qiu*, Wenzheng Jiang*. Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway. Int. J. Mol. Sci. 2021, 22(8), 3807.


    44. Huang Chen, Aiwu Bian, Lian-Fang Yang, Xuan Yin, Jie Wang, Chaowen Ti, Ying Miao, Shihong Peng, Shifen Xu, Mingyao Liu*, Wen-Wei Qiu*, Zhengfang Yi*. Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Oncogene 2021, 40(8), 1440-1457.


    43. Shihong Peng, Jie Wang, Huang Chen, Pan Hu, Xiao-Long He, Yundong He, Minna Wang, Wenshu Tang, Qiurui He, Ying-Ying Wang, Jiayi Xie, Dandan Guo, Shancheng Ren, Mingyao Liu, Wen-Wei Qiu*, Zhengfang Yi*. Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain. Cell Biol. Toxicol.2020, 36(5), 399-416.


    42.  Jie Wang, Xiang-Zhong Gu, Li-Ming He, Chen-Chen Li, Wen-Wei Qiu*. Synthesis of ursodeoxycholic acid from plant-source (20S)-21-hydroxy-20-methylpregn-4-en-3-one. Steroids 2020, 157, 108600.


    41. Jinhua Wang, Yajing Xing, Yingying Wang, Yundong He, Liting Wang, Shihong Peng, Lianfang Yang, Jiuqing Xie, Xiaotao Li, Wen-Wei Qiu*, Zhengfang Yi1* and Mingyao Liu*. A novel BMI-1 inhibitor QW24 for the treatment of stem-likecolorectalcancer. J. Exp. Clin. Cancer Res. 2019, 38, 422.

    40. Huiqing Chen, Yajing Xing, Jia Xie, Jiuqing Xie, Dong Xing,  Jie Tang, Fan Yang, Zhengfang Yi* and Wen-Wei Qiu*. Synthesis and biological evaluation of 3-nitro-4-chromanone derivatives as potential antiproliferative agents for castration-resistant prostate cancer. RSC Advances 2019, 9, 33794–33799.

    39. Zhen Chen, TuoShao, Wei Gao,  Hualong Fu,  ThomasLee Collier, Jian Rong, Xiaoyun Deng, Qingzhen Yu, Xiaofei Zhang, April T. Davenport, James B. Daunais, Hsiao-Ying Wey, Yihan Shao, Lee Josephson, Wen-Wei Qiu*, and StevenLiang*. Synthesis and Preliminary Evaluation of [11C]GNE-1023 as a Potent PET Probe for Imaging Leucine-Rich Repeat Kinase 2(LRRK2) in Parkinson’s Disease. ChemMedChem 2019, 14, 1580-1585.

    38.  Jie Bai, Jia Xie, Yajing Xing, Li-Ting Wang, Jiuqing Xie, Fan Yang, Ting Liu, MingyaoLiu, Jie Tang, Zhengfang Yi, Wen-Wei Qiu*, Synthesis and biological evaluation of methylpyrimidine-fused tricyclic diterpene analogs as novel oralanti-late-onset hypogonadism agents,  Eur. J. Med. Chem. 2019, 176, 21-40.

    37.  Jie Bai, Jia Xie, Li-Ting Wang, Yajing Xing, Qian-Ru Jiang, Fan Yang, Jie Tang, Zhengfang Yi*, Wen-Wei Qiu*. Discoveryof methylpyrimidine ring-fused diterpenoid analogs as a novel testosterone synthesis promoter. RSC Advances 2019, 9, 9709–9717.

    36. Huiqing Chen, Jia Xie, Dong Xing, Jinping Wang, Jie Tang, Zhengfang Yi, Fei Xia, Wen-Wei Qiu*, Fan Yang*, Diastereoselective synthesis of 3,3-disubstituted-3-nitro-4-chromanone derivatives as potential antitumor agents. Org. Biomol. Chem. 2019, 17, 1062-1066.


    35. Shi-You Jiang, Hui Li, Jing-Jie Tang, Jie Wang,Jie Luo, Bing Liu, Jin-Kai Wang, Xiong-Jie Shi,Hai-Wei Cui, Jie Tang, Fan Yang,Wei Qi, Wen-Wei Qiu*, Bao-Liang Song*. Discovery of a potent HMG-CoA reductase degrader that eliminatesstatin-induced reductase accumulation and lowers cholesterol. Nat. Commun. 2018, 9, 5138.

    34. Xiao-Long He, Li-Ting Wang, Xiang-Zhong Gu,Jie-Xin Xiao, Wen-Wei Qiu*. A facilesynthesis of ursodeoxycholic acid and obeticholic acid from cholic Acid, Steroids 2018, 140, 173-178.

    33.  Lian-Fang Yang, Yajing Xing, Jie-Xin Xiao, JiaXie, Wei Gao, Jiuqing Xie, Li-Ting Wang, Jinhua Wang, Mingyao Liu, Zhengfang Yi*, Wen-WeiQiu*. Synthesis of Cyanoenone-Modified Diterpenoid Analogs as Novel Bmi-1-MediatedAntitumor Agents. ACS Med. Chem. Lett. 2018, 9, 1105-1110.

    32.  Xiao-Long He, Yajing Xing, Xiang-Zhong Gu, Jie-Xin Xiao, Ying-Ying Wang, Zhengfang Yi, Wen-Wei Qiu*. The synthesis and antitumor activity of lithocholic acid and its derivatives. Steroids 2017, 125, 54-60.

    31. Xu Xiao, Jing-Jie Tang, Chao Peng, Yan Wang, Lin Fu, Zhi-Ping Qiu, Yue Xiong, Lian-Fang Yang, Hai-Wei Cui, Xiao-Long He, Lei Yin, Wei Qi, Catherine C.L. Wong, Yun Zhao, Bo-Liang Li, Wen-Wei Qiu*, Bao-Liang Song*. Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling. Mol. Cell 2017, 66, 154-162.


    30.  Gao Wei, Yalan Wu, Xiao-Long He, Ting Liu, Mingyao Liu, Jian Luo*, Wen-Wei Qiu*. Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption. Eur. J. Med. Chem2017131, 48-67. 

    29.  Ying-Ying Wang, Yuan He, Lian-Fang Yang, Shi-Hong Peng, Xiao-Long He,Jin-Hua Wang, Fang Lv, Yun Hao, Ming-Yao Liu, Zhengfang Yi*, Wen-Wei Qiu*Synthesis of novel diterpenoidanalogs with in-vivo antitumoractivity. Eur. J. Med. Chem2016120, 13-25. 

    28. Hai-Wei Cui, Shihong Peng, Xiang-Zhong Gu, Huang Chen, Yuan He, Wei Gao , Fang Lv,Jin-Hua Wang, Yan Wang, Jia Xie, Ming- Yao Liu, Zhengfang Yi*, Wen-Wei Qiu*. Synthesisand biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosteronederivatives as antitumor agents. Eur. J. Med. Chem2016111, 126-137.



    27. Ying-Ying Wang, Yuan-Xue Gao, Wei Gao, Yuan Xu, Ya-Zhou Xu, Yun-Jie Wang, Sai Chang, Li-Gang Yu, Lu-Yong Zhang, Hong Liao, Lian-Fang Yang, Tao Pang*, Wen-Wei Qiu*. Design, synthesis and biological evaluation of tricyclic diterpene derivatives as novel neuroprotective agents against ischemic brain injury. Eur. J. Med. Chem. 2015, 103, 396-408.



    26. Hai-Wei Cui,  Yuan He, Jinhua Wang, Wei Gao, Ting Liu, Min Qin, Xue Wang, Cheng Gao, Yan Wang, Ming-Yao Liu, Zhengfang Yi *, Wen-Wei Qiu*. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents. Eur. J. Med. Chem. 2015, 95, 240-248. 


    25.  Li-Gang Yu, Teng-Feng Ni, Wei Gao, Yuan He, Ying-Ying Wang, Hai-Wei Cui, Cai-Guang Yang, Wen-Wei  Qiu*. The synthesis and antibacterial activity of pyrazole-fused tricyclic diterpene derivatives. Eur. J. Med. Chem. 2015, 90, 10-20.


    24.  Gao Cheng, Dai Fu-Jun, Cui Hai-Wei, Peng Shi-Hong, He Yuan, Wang Xue, Yi Zheng-Fang*, Qiu Wen-Wei*. Synthesis of Novel Heterocyclic Ring-Fused 18β-Glycyrrhetinic Acid Derivatives with Antitumor and Antimetastatic Activity. Chem. Biol. Drug. Des.2014, 84, 223-233.







    23.Jun Xu‚ Zhenxi Li‚ Jian Luo‚ Fan Yang‚ Ting Liu‚ Mingyao Liu‚* Wen-Wei Qiu‚* and Jie Tang*. Synthesis and Biological Evaluation of Heterocyclic Ring-fused Betulinic Acid Derivatives as Novel Inhibitors of Osteoclast Differentiation and Bone Resorption. J. Med. Chem. 2012 55‚ 3122-3134. (Highlighted by "SicBX")



    22.Hui Li‚ Hui Zou‚ Lixin Gao‚ Ting Liu‚ Fan Yang‚ Jingya Li‚ Jia Li‚* Wen-Wei Qiu‚* and Jie Tang. Synthesis and Biological Evaluation of Oleanolic Acid Derivatives as Novel Inhibitors of Protein Tyrosine Phosphatase 1B. Heterocycles201285‚ 1117-1139.


    21.   Hui Li,  Jin-Ping Wang,  Fan Yang, Ting Liu,  Wen-Wei Qiu, Jing-Ya Li, Jia Li,*  Jie Tang. Design, synthesis and biological activity evaluation of 2-mercapto-4(3H)-quinazolinone derivatives as novel inhibitors of protein tyrosine phosphatase 1 B. Heterocycles201285‚ 1897-1911.


    20.Wu X‚ Li Z‚ Yang Z‚ Zheng C‚ Chen Y‚ Ye X‚ Lian X‚ Qiu Wen-Wei‚ Yang F‚ Tang J‚ Xiao J‚ Liu M‚ Luo J. CADPE suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of MAPKs/AP-1 and Ca2+-NFAT signaling pathways. J. Bone Miner. Res. 2012, 27, 1298-1308.


    19.Jing-jie Tang‚ Jia-gui Li‚ Wei Qi‚ Wen-wei Qiu‚ Pei-shan Li‚ Bo-liang Li‚ and Bao-Liang Song. Inhibition of SREBP by a small molecule‚ betulin‚ improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab. 201113‚ 44-56.


    18.Wen-wei Qiu‚ Karavadhi Surendra‚ Liang Yin‚ and E. J. Corey‚ Selective formation of six-membered oxa- and carbocycles by the In(III)-activated ring closure of acetylenic substrates. Org. Lett. 201113‚ 5893-5895.


    17.Karavadhi Surendra‚ Wen-wei Qiu‚ and E. J. Corey. A powerful new construction of complex chiral polycycles by an indium(III)-catalyzed cationic cascade. J. Am. Chem. Soc. 2011133‚ 9724-9726.


    16.Chun Li‚ Wen-wei Qiu‚ Zhengfeng Yang‚ Jian Luo‚ Fan Yang*‚ Ming-yao Liu‚ Juan Xie and Jie Tang*. Steroslective synthesis of some methyl-substituted steroid hormones and their in vitro cytotoxic activity against human gastric cancer cell line MGC-803. Steroids201075‚ 859-869.


    15.Cheng-hai Li‚ Zheng-feng Yang‚ Zhen-xi Li‚ Yu Ma‚ Li-peng Zhang‚ Chun-bing Zheng‚ Wen-wei Qiu‚ Xian Wu‚ Xiu Wang‚ Hui Li‚ Jie Tang‚ Min Qian‚ Da-li Li1‚ Ping Wang‚ Jian Luo‚‚ Ming-yao Liu. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways. J. Bone. Miner. Res. 201126‚ 644-656.


    14.Cheng-hai Li‚ Zheng-feng Yang‚ Chun-yan Zhai‚ Wen-wei Qiu‚ Dali Li‚ Zheng-fang Yi‚ Lei Wang‚ Jie Tang‚ Min Qian‚ Jian Luo‚ and Ming-yao Liu. Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway. Mol. Cancer. 20109(73), 1-13.


    13.Wen-wei Qiu‚ Qiang Shen‚ Fan Yang‚ Bo Wang‚ Hui Zou‚ Jing-ya Li‚ Jia Li*‚ Jie Tang*. Synthesis and biological evaluation of heterocyclic ring-  substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. Bioorg. Med. Chem. Lett. 2009 19‚ 6618-6622.


    12. Wen-wei Qiu‚ Linmei He‚ Qi Chen‚ Wanrong Luo‚ Zhichao Yu‚ Fan Yang*‚ Jie Tang*. Imidazolium-modified poly(L-leucine) catalyst: an efficient and recoverable catalyst for Juliá–Colonna reactions. Tetrahedron Lett. 200950‚ 5225-5227.


    11.Wen-wei Qiu‚ Jie Xu‚ Xin Li‚ Li Zhong‚ Jing-ya Li‚ Jia Li‚ Fa-jun Nan. Design and synthesis of matrix metalloprotease photoaffinity trimodular probes. Chin. J. Chem. 200927‚ 825-833.


    10.Bo Wang‚ Fan Yang‚ Yifan Shan‚ Wen-wei Qiu *‚ Jie Tang *.Highly efficient synthesis of capsaicin analogues by condensation of vanillylamine and acyl chlorides in a biphase H2O/CHCl3 system. Tetrahedron200965‚ 5409-5412.


    9.Chun Shen‚ Wen-wei Qiu* Jie Tang. Enantioselective cyano-ethoxycarbonylation of aldehydes catalyzed by bifunctional salen-Ti complex. Chin. J. Org. Chem. 200929‚ 426-431.


    8.Yong-hua Gong‚ Wen-wei Qiu‚ Fan Yang‚ Pierre Audebert‚ Gilles Clavier‚ Fabien Miomander‚ Jie Tang*. Pyridinium conjugated ferrocenes with thien and bithien bridges: synthesis and electrochemical properties. Chin. J. Chem.200927‚ 1515-1522.


    7.Xiu-ling Xu‚ Wen-wei Qiu‚ Qing Zhou‚ Pierre Audebert‚ Jie Tang*‚ Fan Yang*‚ Zhen-rong Sun*‚ Nonlinear Optical Absorption Properties of Two ultisubstituted p-Dimethylaminophenyl- ethenyl Pyridiniums. J. Phy. Chem. B2008112‚ 4913-4917.


    6.Wen-wei Qiu‚ Jie Xu‚ Jing-Ya Li‚ Jia Li‚ and Fa-Jun Nan. Activity-based protein profiling for type I methionine aminopeptidase by using photo-affinity trimodular probes. ChemBioChem. 20078‚ 1351-1358.


    5.Fan Yang‚ Xiu-Ling Xu‚ Yong-Hua Gong‚ Wen-Wei Qiu‚ Zhen-Rong Sun‚ Jin-Wei Zhou‚ Pierre Audebert and Jie Tang. Synthesis and nonlinear optical absorption properties of two new conjugated ferrocene-bridge-pyridinium compounds. Tetrahedron200763‚ 9188-9194.


    4.Wen-wei Qiu‚ Jie Xu‚ Da-Zhi Liu‚ Jing-Ya Li‚ Yang Ye‚ Xing-Zu Zhu‚ Jia Li and Fa-Jun Nan. Design and synthesis of a biotin-tagged photoaffinity probe of paeoniflorin. Bioorg. Med. Chem. Lett. 200616‚ 3306-3309.


    3.徐军‚ 王晋萍‚ 钱辰旭‚ 仇文卫*‚ 杨帆‚ 汤杰. 白桦脂酸的研究进展. 生命科学.  201123‚ 503-510.


    2.仇文卫‚ 汤杰. 化学小分子探针在药物发现中的应用. 化学教学. 20099‚ 1-4.


    1.王博‚ 仇文卫*‚ 喻艳华‚ 杨帆‚ 汤杰. 山楂酸的研究进展. 生命科学. 200921‚ 264-269.


    已申请中国发明专利、PCT专利、美国、欧洲、日本、韩国、马来西亚、阿联酋等100余件发明专利,其中已授权52件。


    代表性授权专利:

    1. 仇文卫,宋保亮,江倩茹,江世友,史熊杰,李晨晨,胆酸衍生物及其在降胆固醇中的应用专利号:ZL 202010350743.7, 授权公告日20238月8日。

    2. 仇文卫,李晨晨,顾向忠,蒋澄宇,吴殊岚,林林,一种熊去氧胆酸的纯化方法,专利号:ZL 202110779101.3授权公告日2023825日。

    3. 仇文卫,李晨晨,蒋澄宇,顾向忠,叶如飞一种高纯度植物源7-酮基石胆酸的合成方法,专利号:ZL 202211128887.3,授权公告日:2024年2月9日。

    4. 顾向忠,仇文卫,李晨晨,蒋澄宇,吴殊岚,叶如飞,一种胆固醇的合成方法,专利号:ZL 202210227825.1,授权公告日:2023年414日。

    5. 仇文卫,宋保亮,何丽明,刘源彬,一种三环二萜类似物及其合成和应用, 专利号:ZL 202111007490.4,授权公告日:2024年22日。

    6. 仇文卫,王杰,一种以BA为原料合成熊去氧胆酸的方法, 专利号:ZL 201911222943.8, 授权公告日:20219月14日。

    7. 仇文卫,易正芳,汤杰,刘明耀,白捷,王李婷,谢佳,邢雅婧,三环二萜并2-甲基嘧啶类似物及其制备方法和应用专利号:ZL 201811598028.4授权公告日:2021127日。

    8. 顾向忠,蒋澄宇,仇文卫,高伟,甾体化合物3位羟基构型翻转方法用,专利号:ZL 201810827845.6授权公告日:2021611日。

    9. 仇文卫,一种奥贝胆酸的中间体3α-羟基-7--5β-胆甾烷-24-酸的合成方法,专利号:ZL 201710226997.6专利授权日期:20201222日。

    10. 仇文卫,宋保亮,肖旭,汪炎,唐静洁,王李婷,杨连芳,一种胆固醇-Biotin分子探针及其制备方法和应用,专利号:ZL 201710017878.X,授权公告日:2019614

    11. 仇文卫,蒋澄宇,顾向忠,林林,地塞米松中间体的制备方法,专利号:ZL 201510847620.3授权公告日:2017825日。

    12. 仇文卫,易正芳,陈煌,彭世鸿,崔海伟,汪炎,何小龙,刘明耀,表雄酮和去氢表雄酮糖基化衍生物及其制备方法和应用,专利号:ZL 201510587233.0授权公告日:2017118日。



    荣誉及奖励